Benjamin L. Oakes insider trades

Open-market stock purchases and sales by Benjamin L. Oakes, President, CEO at Scribe Therapeutics, Inc, from SEC Form 4 filings since Mar 13, 2026.

Recent trades

DateStockTradeValue
Jul 23, 2026SCTX Scribe Therapeutics, IncBought (not open market)—
Jul 23, 2026SCTX Scribe Therapeutics, IncBought (not open market)—
Mar 13, 2026SCTX Scribe Therapeutics, IncBought (not open market)—

Companies traded

  • SCTX Scribe Therapeutics, Inc: other filings, last Jul 23, 2026

Get free alerts when Benjamin L. Oakes files a new trade →